TRBCX (TRBCX) Stock Price & Analysis
TRBCX (TRBCX) fell 0.37% to USD 214.14 as of September 9, 2026 at 01:43 UTC, according to Nexqual real-time market data.
TRBCX last closed at USD 214.14; the session ranged USD 214.14–214.14 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 179.68–227.75 (NAS). Source: Nexqual, September 9, 2026 at 01:43 UTC.
Key Statistics (as of September 9, 2026 at 01:43 UTC)
| Price | USD 214.14 |
|---|---|
| Change | ▼ 0.37% (down) |
| Previous Close | USD 214.14 |
| Open | USD 214.14 |
| Day Range | USD 214.14 – 214.14 |
| 52-Week Range | USD 179.68 – 227.75 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (TRBCX)
Nexqual's technical model rates TRBCX "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of September 9, 2026 at 01:43 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 53.5 (neutral) |
| vs SMA50 | Above (USD 211.37) |
| MACD | 0.59 (positive) |
Financial Health Score (TRBCX)
Nexqual rates TRBCX's overall financial health "Mixed" across five dimensions, as of September 9, 2026 at 01:43 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RPMGX | T. Rowe Price Mid-Cap Growth Fu | USD 99.53 | ▼ 1.64% |
| PRHSX | T. Rowe Price Health Sciences F | USD 94.15 | ▼ 2.65% |
| PRFDX | T. Rowe Price Equity Income Fd | USD 45.5 | ▼ 1.28% |
| PRSCX | T. Rowe Price Science and Techn | USD 70.45 | ▲ 0.67% |
| PRNHX | T. Rowe Price New Horizons Fund | USD 57.46 | ▼ 0.31% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 01:43 UTC. This page is informational and not investment advice.